ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ABSI vs MXCT // EV/EBITDA & P/E VALUATION

Absci Corporation (NASDAQ) VS. MaxCyte Inc. (NASDAQ) • 15-METRIC TALLY: ABSI 2 — MXCT 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABSI VS. MXCT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ABSI MXCT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -27.10% -7.90 MXCT /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -4.53% -20.26% +15.73 ABSI /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -5.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 MXCT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.7 65.4 -7.62 MXCT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.08B $178.5M $1.90B ABSI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ABSI REV MXCT REV ABSI GROSS % MXCT GROSS % ABSI FCF MXCT FCF
FY 2025 $0 $21.0M — 98.0% -$94.0M -$36.2M
FY 2024 $4.5M $22.2M — 98.0% -$72.8M -$29.3M
FY 2023 $5.7M $19.5M — — -$64.6M -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABSI // BETA —
MXCT // BETA —